Moleculin Biotech Shares Tumble After Warrant Exercise Deal; Company to Issue Replacement Warrants
Moleculin Biotech Inc. (NASDAQ: MBRX) saw its stock fall 34.3% in premarket trading after announcing an agreement with certain warrant holders to immediately exercise outstanding warrants. The deal will bring in roughly $8.3 million in gross proceeds at $3.90 per share while creating new unregistered warrants that could lead to further dilution pen…